Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection

被引：0
|
作者：
机构：
来源：
| 1600年 / American Society for Biochemistry and Molecular Biology Inc., Bethesda, United States卷 / 265期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] STRUCTURAL REQUIREMENTS FOR C3D,G EPSTEIN-BARR-VIRUS RECEPTOR (CR-2 CD21) LIGAND-BINDING, INTERNALIZATION, AND VIRAL-INFECTION
    CAREL, JC
    MYONES, BL
    FRAZIER, B
    HOLERS, VM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1990, 265 (21) : 12293 - 12299
  • [2] Evidence for a new transcript of the Epstein-Barr virus C3d receptor (CR2, CD21) which is due to alternative exon usage
    Barel, M
    Balbo, M
    Frade, R
    MOLECULAR IMMUNOLOGY, 1998, 35 (16) : 1025 - 1031
  • [3] The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding
    Prota, AE
    Sage, DR
    Stehle, T
    Fingeroth, JD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (16) : 10641 - 10646
  • [4] CHARACTERIZATION OF A LYMPHOCYTE-T EPSTEIN-BARR VIRUS C3D RECEPTOR (CD21)
    FINGEROTH, JD
    CLABBY, ML
    STROMINGER, JD
    JOURNAL OF VIROLOGY, 1988, 62 (04) : 1442 - 1447
  • [5] MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, enhancing the viral infection of Burkitt lymphoma cells
    Molina, Ester
    Garcia-Gutierrez, Lucia
    Junco, Vanessa
    Perez-Olivares, Mercedes
    de Yebenes, Virginia G.
    Blanco, Rosa
    Quevedo, Laura
    Acosta, Juan C.
    Marin, Ana V.
    Ulgiati, Daniela
    Merino, Ramon
    Delgado, M. Dolores
    Varela, Ignacio
    Regueiro, Jose R.
    Moreno de Alboran, Ignacio
    Ramiro, Almudena R.
    Leon, Javier
    ONCOGENE, 2023, 42 (45) : 3358 - 3370
  • [6] INTRACELLULAR INTERACTIONS OF THE EPSTEIN-BARR-VIRUS AND C3D RECEPTOR (CR-2, CD21)
    BAREL, M
    BALBO, M
    GAUFFRE, A
    FRADE, R
    FASEB JOURNAL, 1995, 9 (04): : A806 - A806
  • [7] MYC directly transactivates CR2/CD21, the receptor of the Epstein–Barr virus, enhancing the viral infection of Burkitt lymphoma cells
    Ester Molina
    Lucía García-Gutiérrez
    Vanessa Junco
    Mercedes Perez-Olivares
    Virginia G. de Yébenes
    Rosa Blanco
    Laura Quevedo
    Juan C. Acosta
    Ana V. Marín
    Daniela Ulgiati
    Ramon Merino
    M. Dolores Delgado
    Ignacio Varela
    José R. Regueiro
    Ignacio Moreno de Alborán
    Almudena R. Ramiro
    Javier León
    Oncogene, 2023, 42 : 3358 - 3370
  • [8] Isolating the Epstein-Barr virus gp350/220 binding site on complement receptor type 2 (CR2/CD21)
    Young, Kendra A.
    Chen, Xiaojiang S.
    Holers, V. Michael
    Hannan, Jonathan P.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (50) : 36614 - 36625
  • [9] C3D AND EPSTEIN-BARR-VIRUS (CR2/CD21 LIGANDS) STIMULATE CELLS OF AN HTLV-I LINE, MT-2
    KURAYA, M
    SATO, T
    FUJITA, T
    MICROBIOLOGY AND IMMUNOLOGY, 1995, 39 (02) : 145 - 151
  • [10] T cell activation induced by cross-linking CD3 and CD28 leads to silencing of Epstein-Barr virus/C3d receptor (CR2/CD21) gene and protein expression
    Masilamani, M
    von Seydlitz, E
    Bastmeyer, M
    Illges, H
    IMMUNOBIOLOGY, 2002, 206 (05) : 528 - 536
12345